💊 Drugs A-Z 🧬 Targets 🛠 Tools 📚 Guides
All Drugs Drug Classes Therapeutic Areas Side Effects
Guides Glossary Timeline
Comparisons Drug Journeys Drug Families
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Tinidazole

CHEMBL1220 Phase 4 Approved Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
247.3 g/mol
LogP
-0.4
Phase
4

This antibiotic and antiprotozoal medication is used to treat infections caused by certain bacteria and parasites, including bacterial vaginosis, trichomoniasis, giardiasis, and amebiasis. It works by entering the cells of microorganisms and damaging their DNA. Alcohol must be strictly avoided during treatment and for several days afterward due to a severe reaction similar to disulfiram.

Molecular Weight

247.2700 g/mol

LogP

-0.40

TPSA

106.00 Ų

Lipinski RO5

Pass

Therapeutic Areas

Malaria

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

                            
                            
                        

                    

                


                
                

                    

                    

                        
Embed this structure

                        

                        

                            
                            
                        

                    

                

                

                
                

                    
SMILES

                    
CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C

                

                

                
                

                    
InChI

                    
InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3

                

                

                

                    
                    

                        
Molecular Formula

                        
C8H13N3O4S

                    

                    
                    

                        
HBD / HBA

                        
- / 5

                    

                    
                    

                        
Rotatable Bonds

                        
4

                    

                    
                    
                    

                        
Heavy Atoms

                        
16

                    

                    
                

            


            
            

                
                


    
    
        
    
    
    
No targets recorded

    
    
Target interaction data is not yet available for this drug.

    



                
            


            
            

                
                


    
    
        
    
    
    
No interactions recorded

    
    
Drug interaction data is not yet available for this compound.

    



                
            


            
            

                
                


    
    
        
    
    
    
No side effects recorded

    
    
Side effect data is not yet available for this drug.

    



                
            


            
            
            

                
Frequently Asked Questions

                

                    
                    

                        
                        

                            
This antibiotic and antiprotozoal medication is used to treat infections caused by certain bacteria and parasites, including bacterial vaginosis, trichomoniasis, giardiasis, and amebiasis. It works by entering the cells of microorganisms and damaging their DNA. Alcohol must be strictly avoided during treatment and for several days afterward due to a severe reaction similar to disulfiram.

                        

                    

                    

                    

                    

                    

                    

                        
                        

                            
Yes, Tinidazole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

                        

                    

                

            

            

            
            

            
            

            
            
{# References & Data Sources section for drug detail pages.
   Renders standard pharmacological database links plus the drug's data_sources field. #}


    
References & Data Sources

    
    
        
        
  • 
            
            
                ChEMBL — European Bioinformatics Institute (EBI).
                CHEMBL1220.
                Open-access bioactivity database.
            
        
    • 
        
        
        
  • 
            
            
                PubChem — National Center for Biotechnology Information (NCBI).
                CID 5479.
                Chemical information database.
            
        
    • 
        
        
        
        
    

    
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.




        


        
        
    


    



    
Medical Disclaimer

    

        This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
    

    

        Data sources:
        ChEMBL,
        PubChem,
        DailyMed.